Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma
✍ Scribed by Thomas Schneider; Michael Sailer; Siegfried Ansorge; Raimund Firsching; Dirk Reinhold
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 184 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The transforming growth factors type PI, p2, and p,.2 suppress multidrug transport in human pat-1 glioblastoma cells and even in cells that strongly overexpress mdr genes and are resistant to inhibition of multidrug transport by chemosensitizers. Thus, inhibition of multidrug transport by cytokines
## Background: Transforming growth factor (tgf)-beta has been shown to be a potent stimulator of collagen production by fibroblasts, and could play a role in the pathogenesis of systemic sclerosis (ssc). ## Objective: To study the possible involvement of tgf-beta1 gene polymorphism in japanese pa